Which medicines are commonly combined with Yervoy (ipilimumab)?
Yervoy is typically used with other anti-cancer drugs that target the PD-1/PD-L1 pathway or with certain targeted therapies, depending on the cancer type. In practice, the most frequent combinations involve pairing Yervoy with a PD-1 inhibitor such as nivolumab (often called an “opdivo + yervoy” regimen) for multiple cancers.
What combination is most well-known: Yervoy with nivolumab?
The best-known Yervoy combination is with nivolumab (a PD-1 inhibitor). This pairing is used across several tumor types where combination immunotherapy is standard.
Can Yervoy be combined with PD-1 inhibitors other than nivolumab?
Yes. Yervoy can also be combined with other agents in the same immunotherapy class (PD-1/PD-L1–targeting strategies), depending on the specific disease and approved regimen.
Which targeted therapies can be combined with Yervoy?
In some cancers (for example, certain kidney and liver cancers), Yervoy is combined with other systemic therapies, including targeted agents. The exact allowed/approved partners depend on the indication.
What about chemo or radiation with Yervoy?
Yervoy may be used in combination with radiation or chemotherapy in certain settings, but the specific “can combine with” list is highly indication-dependent and depends on which regimen is approved or supported by clinical evidence.
Why the answer changes depending on your diagnosis
The drugs that can be combined with Yervoy are not universal. Approved and studied combinations vary by cancer type (and sometimes by prior treatments), so the “right” add-on drug is different for melanoma, lung cancer, kidney cancer, and other indications.
Tell me your cancer type to get the exact combo list
If you share the cancer type (and line of therapy, if you know it), I can list the specific drugs that are used together with Yervoy for that indication.